Background: "Goodpasture syndrome" refers to a condition in which an uncommon but life-threatening autoimmune illness that affects the lungs and kidneys. Disease develops when the body's immune system produces antibodies against collagen in the lung a type of protein that helps animals create tissue. The autoimmune disease Goodpasture syndrome affects the lungs and kidneys. and can be fatal. Patient information:A 34-year-oldmale, having chief complaint of shortness of breath, chest pain, fatigue, coughing and weakness reported. His weight was 56 kg.He was admitted in hospital on date 06-07-2021. Clinical findings: The patient appeared to be awake and oriented with individuals on general inspection. There are no high-risk variables. He was pale, anxious, and dyspnoeic throughout the examination, and he had roles in the lungs. Patients with clinical symptoms that are very similar to those of our case have lately been described. He has circulating antibodies. Medical Management: Oral immunosuppressive drugs like cyclophosphamide and corticosteroids are frequently prescribed. These drugs suppress the immune system's generation of Goodpasture syndrome antibodies. In some circumstances, intravenous corticosteroids may be required to control pulmonary bleeding. Nursing Management: Administered fluid replacement (DNS and RL), maintained intake and output charts, and hourly monitored all vital signs. Conclusion: Development of antibodies against the glomerular basement membrane and alveolus causes Goodpasture syndrome, which results in impairment to renal and pulmonary function.

Anti-glomerular, basement membrane, alveolar haemorrhage, glomerulonephritis.